| 000 | 01855 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514023808.0 | ||
| 264 | 0 | _c20020227 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a0284-186X | ||
| 024 | 7 |
_a10.1080/02841860152708198 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBegg, A C | |
| 245 | 0 | 0 |
_aHypoxia and perfusion measurements in human tumors--initial experience with pimonidazole and IUdR. _h[electronic resource] |
| 260 |
_bActa oncologica (Stockholm, Sweden) _c2001 |
||
| 300 |
_a924-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAntibodies |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aDiffusion |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xblood supply |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xblood supply |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxia _xphysiopathology |
| 650 | 0 | 4 |
_aIdoxuridine _xadministration & dosage |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNitroimidazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aNucleic Acid Synthesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aRadiation-Sensitizing Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aRectal Neoplasms _xblood supply |
| 650 | 0 | 4 | _aRegional Blood Flow |
| 650 | 0 | 4 | _aSpecimen Handling |
| 650 | 0 | 4 |
_aUterine Cervical Neoplasms _xblood supply |
| 700 | 1 | _aJanssen, H | |
| 700 | 1 | _aSprong, D | |
| 700 | 1 | _aHofland, I | |
| 700 | 1 | _aBlommestijn, G | |
| 700 | 1 | _aRaleigh, J A | |
| 700 | 1 | _aVaria, M | |
| 700 | 1 | _aBalm, A | |
| 700 | 1 | _aVan Velthuyzen, L | |
| 700 | 1 | _aDelaere, P | |
| 700 | 1 | _aSciot, R | |
| 773 | 0 |
_tActa oncologica (Stockholm, Sweden) _gvol. 40 _gno. 8 _gp. 924-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/02841860152708198 _zAvailable from publisher's website |
| 999 |
_c11754562 _d11754562 |
||